InnoCare Optoelectronics held an investor conference on December 16, 2025, where company chairman James Yang pointed out that while the global medical device market grows annually by about 5–8%, ...
Section 1. Purpose and Policy. Americans deserve access to the best medical treatments and research infrastructure in the world. In 2023, the Food and Drug Administration (FDA) completed a review of ...
President Donald Trump on Thursday signed an executive order that would ease cannabis restrictions by reclassifying it with lower-risk drugs. PRESIDENT DONALD TRUMP: We live with chronic medical ...
WASHINGTON — President Donald Trump signed an executive order Thursday to speed the reclassification of marijuana from a Schedule I drug, a significant change that would not federally legalize ...
Forbes contributors publish independent expert analyses and insights. I write about tech that impacts my small business - and yours. Ask any owner of a small or midsized company about AI and they'll ...
Different AI models win at images, coding, and research. App integrations often add costly AI subscription layers. Obsessing over model version matters less than workflow. The pace of change in the ...
The FDA now accepts RWE for device submissions without needing identifiable patient data, facilitating the use of large, de-identified databases. This change addresses previous limitations that ...
A sweeping review of more than 2,500 studies reveals that despite booming public enthusiasm, cannabis has strong scientific support for only a few medical uses, leaving most popular claims—like relief ...
Researchers found a chasm between the health reasons for which the public seeks out cannabis and what gold-standard science actually shows about its effectiveness. By Jan Hoffman To treat their pain, ...
Texas Attorney General Ken Paxton filed an antitrust lawsuit against healthcare technology giant Epic Systems, alleging the company’s setup can block parents from accessing their children’s health ...
There is "insufficient" evidence supporting the use of cannabis or cannabinoids for most medical purposes, a new review has concluded. "We reviewed the totality of the evidence—over a thousand studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback